43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 09
00:49 UTC
|
SJ
Stella-Jones
|
◎ Target | firm only | Buy | C$104.00→ C$99.00-4.8% |
|
Aug 09
00:49 UTC
|
SJ
Stella-Jones
|
◎ Target | firm only | Sec→ r Perform | C$95.00→ C$92.00-3.2% |
|
Aug 09
00:49 UTC
|
SJ
Stella-Jones
|
◎ Target | firm only | Outperform | C$90.00→ C$83.00-7.8% |
|
Aug 09
00:49 UTC
|
SIS
Savaria
|
◎ Target | firm only | Outperform | C$35.00→ C$38.00+8.6% |
|
Aug 09
00:49 UTC
|
SIS
Savaria
|
◎ Target | firm only | Buy | C$35.00→ C$37.00+5.7% |
|
Aug 09
00:49 UTC
|
SIS
Savaria
|
◎ Target | firm only | Buy | C$36.00→ C$39.00+8.3% |
|
Aug 09
00:49 UTC
|
SION
Sionna Therapeutics
|
◎ Target | Yatin Suneja ★★☆☆☆ #2369 | Buy | $50.00→ $60.00+20.0% |
|
Aug 09
00:49 UTC
|
SI
Shoulder Innovations
|
◎ Target | Ryan Zimmerman ★★★☆☆ #1236 | Buy | $24.00→ $26.00+8.3% |
|
Aug 09
00:49 UTC
|
SHC
Sotera Health
|
◎ Target | Brendan Digan not yet tracked | Buy | $23.00→ $25.00+8.7% |
|
Aug 09
00:49 UTC
|
SHC
Sotera Health
|
◎ Target | Luke Sergott ★★★★★ #198 | Overweight | $19.00→ $22.00+15.8% |
|
Aug 09
00:49 UTC
|
SHC
Sotera Health
|
◎ Target | Casey Woodring ★★★★★ #94 | Neutral | $16.00→ $18.00+12.5% |
|
Aug 09
00:49 UTC
|
SHAZ
SharonAI Holdings, Inc. Class A Common Stock
|
◎ Target | Brett Knoblauch ★☆☆☆☆ #3183 | Overweight | $116.00→ $109.00-6.0% |
|
Aug 09
00:49 UTC
|
SGI
Somnigroup International
|
◎ Target | Keith Hughes ★★★☆☆ #1166 | Buy | $115.00→ $100.00-13.0% |
|
Aug 09
00:49 UTC
|
SGI
Somnigroup International
|
◎ Target | Dan Silverstein not yet tracked | Buy | $105.00→ $94.00-10.5% |
|
Aug 09
00:49 UTC
|
SG
Sweetgreen
|
◎ Target | Logan Reich ★★★☆☆ #1246 | Outperform | $7.00→ $6.50-7.1% |
|
Aug 09
00:49 UTC
|
SG
Sweetgreen
|
◎ Target | Dennis Geiger ★★★☆☆ #1368 | Neutral | $7.00→ $6.50-7.1% |
|
Aug 09
00:49 UTC
|
SG
Sweetgreen
|
◎ Target | Jon Tower ★★★★☆ #797 | Buy | $10.00→ $8.00-20.0% |
|
Aug 09
00:49 UTC
|
SG
Sweetgreen
|
◎ Target | Brian Bittner ★★★★★ #310 | Outperform | $10.00→ $8.50-15.0% |
|
Aug 09
00:49 UTC
|
SG
Sweetgreen
|
◎ Target | Anthony Trainor ★★★☆☆ #1295 | Equal Weight | $7.00→ $6.00-14.3% |
|
Aug 09
00:49 UTC
|
SG
Sweetgreen
|
◎ Target | Andrew M. Charles not yet tracked | Hold | $8.00→ $5.00-37.5% |
|
Aug 09
00:49 UTC
|
SEZL
Sezzle
|
◎ Target | Kyle Peterson ★★★☆☆ #1234 | Buy | $166.00→ $172.00+3.6% |
|
Aug 09
00:49 UTC
|
SEZL
Sezzle
|
◎ Target | Ryan Tomasello ★★★★★ #146 | Market Perform | $190.00→ $155.00-18.4% |
|
Aug 09
00:49 UTC
|
SERV
Serve Robotics
|
◎ Target | Colin Rusch ★☆☆☆☆ #3122 | Outperform | $20.00→ $7.00-65.0% |
|
Aug 09
00:49 UTC
|
SEI
Solaris Energy Infrastructure
|
◎ Target | Sean Milligan ★☆☆☆☆ #3161 | Buy | $97.00→ $98.00+1.0% |
|
Aug 09
00:49 UTC
|
SBRY
J Sainsbury
|
◎ Target | firm only | Neutral | GBX 330→ GBX 346+4.8% |
|
Aug 09
00:49 UTC
|
SARO
StandardAero
|
◎ Target | Gavin Parsons ★★★☆☆ #1354 | Buy | $35.00→ $36.00+2.9% |
|
Aug 09
00:49 UTC
|
RYTM
Rhythm Pharmaceuticals
|
◎ Target | Priyanka Grover ★☆☆☆☆ #3177 | Overweight | $145.00→ $146.00+0.7% |
|
Aug 09
00:49 UTC
|
RXO
RXO
|
◎ Target | Thomas Wadewitz ★★★☆☆ #1189 | Neutral | $26.00→ $23.00-11.5% |
|
Aug 09
00:49 UTC
|
RXO
RXO
|
◎ Target | Ariel Rosa ★★★☆☆ #1465 | Neutral | $30.00→ $23.00-23.3% |
|
Aug 09
00:49 UTC
|
RXO
RXO
|
◎ Target | Jason Seidl ★★★☆☆ #999 | Sell | $19.00→ $17.50-7.9% |
|
Aug 09
00:49 UTC
|
RXO
RXO
|
◎ Target | Lucas Servera ★★★★☆ #956 | Buy | $30.00→ $28.00-6.7% |
|
Aug 09
00:49 UTC
|
RUN
Sunrun
|
◎ Target | Biju Perincheril not yet tracked | Positive | $18.00→ $15.00-16.7% |
|
Aug 09
00:49 UTC
|
RUN
Sunrun
|
◎ Target | Vikram Bagri ★★☆☆☆ #2616 | Buy | $20.00→ $16.00-20.0% |
|
Aug 09
00:49 UTC
|
RSG
Republic Services
|
◎ Target | William Grippin ★★★☆☆ #2191 | Equal Weight | $233.00→ $240.00+3.0% |
|
Aug 09
00:49 UTC
|
RPRX
Royalty Pharma
|
◎ Target | Chris Schott ★★★★☆ #531 | Overweight | $58.00→ $62.00+6.9% |
|
Aug 09
00:49 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Douglas Tsao ★★★☆☆ #1156 | Buy | $34.00→ $41.00+20.6% |
|
Aug 09
00:49 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Yatin Suneja ★★☆☆☆ #2369 | Buy | $36.00→ $42.00+16.7% |
|
Aug 09
00:49 UTC
|
RMD
ResMed
|
◎ Target | Adam Maeder ★★★★☆ #925 | Neutral | $233.00→ $225.00-3.4% |
|
Aug 09
00:49 UTC
|
RMD
ResMed
|
◎ Target | Nathan Treybeck ★★☆☆☆ #2320 | Equal Weight | $225.00→ $215.00-4.4% |
|
Aug 09
00:49 UTC
|
RMD
ResMed
|
◎ Target | Craig Wong-Pan ★★★★☆ #578 | Sec→ r Perform | $234.00→ $244.00+4.3% |
|
Aug 09
00:49 UTC
|
RMD
ResMed
|
◎ Target | Justin Patterson ★★★☆☆ #1653 | Overweight | $260.00→ $255.00-1.9% |
|
Aug 09
00:49 UTC
|
RLAY
Relay Therapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #1065 | Overweight | $27.00→ $30.00+11.1% |
|
Aug 09
00:49 UTC
|
RL
Ralph Lauren
|
◎ Target | Paul Lejuez ★★★★☆ #568 | Buy | $400.00→ $455.00+13.8% |
|
Aug 09
00:49 UTC
|
RL
Ralph Lauren
|
◎ Target | Robert Drbul ★★★★☆ #623 | Buy | $450.00→ $460.00+2.2% |
|
Aug 09
00:49 UTC
|
RL
Ralph Lauren
|
◎ Target | Adrienne Yih ★★★★☆ #764 | Overweight | $439.00→ $463.00+5.5% |
|
Aug 09
00:49 UTC
|
RL
Ralph Lauren
|
◎ Target | Jay Sole ★★★☆☆ #1350 | Buy | $511.00→ $520.00+1.8% |
|
Aug 09
00:49 UTC
|
RL
Ralph Lauren
|
◎ Target | Dana Telsey ★★★☆☆ #1082 | Outperform | $460.00→ $470.00+2.2% |
|
Aug 09
00:49 UTC
|
RKT
Rocket Companies
|
◎ Target | Donald Fandetti ★★★☆☆ #1522 | Equal Weight | $17.00→ $15.00-11.8% |
|
Aug 09
00:49 UTC
|
RKT
Rocket Companies
|
◎ Target | Kyle Joseph ★★☆☆☆ #2687 | Overweight | $22.50→ $20.00-11.1% |
|
Aug 09
00:49 UTC
|
RKT
Rocket Companies
|
◎ Target | Daniel Kurnos ★★☆☆☆ #2725 | Buy | $21.00→ $19.00-9.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.